Celltrion is facing uncertainties over Chairman Seo Jung-jin s potential handover of his management rights to his two sons, Celltrion Board Chairman Seo Jin-seok and Celltrion Healthcare Board Chairman Seo Joon-serk, as it was found recently that his two daughters from an extramarital affair had been recognized last year as his biological children, according to industry officials, Thursday.
The COVID-19 drug under trial
As per The Korea Herald, this phase 3 is the final step in the human tests of the medicine that was named Regkirona or CT-P59. It was mentioned that the trials are being done in 13 nations that include the U.S., South Korea, Romania, and Spain.
Based on the report, the said drug has been approved in Korea for emergency use and was issued an authorization in February. It was then used to treat patients with mild symptoms in adults and those belonging to high-risk groups. Celltrion shared that they did not find any unusual reaction from a group of patients who received the drug.
Celltrion reveals development in COVID-19 phase 3 drug trial econotimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from econotimes.com Daily Mail and Mail on Sunday newspapers.